Login
$GRCE
$1.75 -$0.06 (3.31%) Live

$GRCE SEC Filings

Filed On Filing
16 Nov 2026 SCHEDULE 13G/A
13 Nov 2026 SCHEDULE 13G/A
12 Nov 2026 8-K: Results of Operations and Financial Condition

Princeton, N.J., November 12, 2026 (GLOBE NEWSWIRE) — Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage biopharma company advancing GTx-104, a novel, injectable formulation of nimodipine that has c...

12 Nov 2026 10-Q
05 Nov 2026 Form 4: Opaleye Management Inc., 10% owner

Bought 10,328 shares ($18.5K) · Bought 5,027 shares ($9.06K) · Bought 3,087 shares ($5.48K)

26 Oct 2026 Form 4: Opaleye Management Inc., 10% owner

Bought 21,390 shares ($41.2K) · Bought 66,411 shares ($117K)

21 Oct 2026 Form 4: Opaleye Management Inc., 10% owner

Bought 4,256 shares ($8K)

16 Oct 2026 Form 4: Opaleye Management Inc., 10% owner

Bought 11,233 shares ($21.7K) · Bought 23,485 shares ($45.7K) · Bought 36,347 shares ($68.8K)

13 Oct 2026 Form 4: Opaleye Management Inc., 10% owner

Bought 2,077 shares ($4.19K) · Bought 5,340 shares ($10.9K) · Bought 7,215 shares ($14.6K)

05 Oct 2026 Form 4: Opaleye Management Inc., 10% owner

Bought 38,796 shares ($79K) · Bought 20,000 shares ($41.4K) · Bought 1,694 shares ($3.49K)

01 Oct 2026 Form 4: Opaleye Management Inc., 10% owner

Bought 7,849 shares ($16.4K)

01 Oct 2026 Form 4/A: Opaleye Management Inc., 10% owner

Bought 9,771 shares ($20.5K) · Bought 5,318 shares ($11.2K)

23 Sep 2026 Form 4: Opaleye Management Inc., 10% owner

Bought 9,771 shares ($20.5K) · Bought 5,318 shares ($11.2K)

21 Sep 2026 Form 4: Neugeboren Edward, Director

Granted 12,200 Stock Option (Right to Buy)

21 Sep 2026 Form 4: Davis A Brian, Director

Granted 0 Stock Option (Right to Buy)

21 Sep 2026 Form 4: Kavuru Vimal, Director

Granted 12,200 Stock Option (Right to Buy)

21 Sep 2026 Form 4: Kottayil George, Director

Granted 12,200 Stock Option (Right to Buy)

18 Sep 2026 8-K: Submission of Matters to a Vote of Security Holders

On September 17, 2026, Grace Therapeutics, Inc. (the “Company”) held its Annual Meeting of Stockholders (the “Meeting”). Proxies for the Meeting were solicited pursuant to Section 14(a) of the Securities Exchange Act of 1934, as amended,...

10 Sep 2026 Form 4: Opaleye Management Inc., 10% owner

Bought 9,393 shares ($19.7K) · Bought 5,836 shares ($12.2K)

10 Sep 2026 Form 4: Kohli Prashant, Director

Bought 100,000 shares ($214K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support